Loading clinical trials...

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer | Clinical Trials | Clareo Health

COMPLETEDNCT00095589

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

RATIONALE: New diagnostic procedures such as microsatellite analysis of sediment in the urine may improve the ability to detect bladder cancer without invasive procedures. PURPOSE: Diagnostic trial t...

Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more

RECRUITINGPhase 1

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225 · Non-muscle Invasive Bladder Cancer

RECRUITINGPhase 1/2

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT03317158 · Urothelial Carcinoma, Bladder Cancer

RECRUITINGPhase 2

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582 · Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma, and more

RECRUITINGPhase 1

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 8, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment125

Start dateAug 2004

Last updatedFeb 8, 2019

Condition

Bladder Cancer

Locations shown

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham

Birmingham, Alabama

Stanford Cancer Center

Stanford, California

University of Chicago Cancer Research Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Trial snapshot

Condition

Locations shown

For caregivers